rajarnarayan Profile Banner
Raja Narayan, MD MPH Profile
Raja Narayan, MD MPH

@rajarnarayan

Followers
2K
Following
4K
Media
289
Statuses
2K

Surgical Oncologist @LLUHealth focused in Liver & Pancreas. @StanfordSurgery, @MGHSurgery, & @BrighamSurgery trained. Former @khanacademy Medical Instructor.

Inland Empire, CA
Joined December 2010
Don't wanna be here? Send us removal request.
@rajarnarayan
Raja Narayan, MD MPH
21 hours
A fantastic @SocSurgOnc line up with @AParikhMD @LLUSurgOnc and @JamesNLuo @MassGenBrigham sharing Pancreas cases with the inimitable Dr. Peter Allen from @DukeSurgOnc moderating. Looking forward to it
@SocSurgOnc
Society of Surgical Oncology
1 day
Don’t miss the upcoming CGSO Videoconference: Pancreas! This session will feature two live case presentations by CGSO Fellows, Drs. Anup Parikh and James Luo, and guest expert Dr. Peter Allen. Secure your spot now: https://t.co/FTnFEBSA83
Tweet media one
0
3
5
@rajarnarayan
Raja Narayan, MD MPH
24 hours
Congrats @gregDsacks! Phenomenal work on decision making in surgery getting recognized by the @NIH with an uber competitive K08 👏👏👏
@NYULH_Surgery
NYU Langone Surgery
2 days
Congratulations to Greg Sacks, MD, PhD, MPH, on receiving a prestigious NIH K08 early career research award for his project, "Optimizing Surgical Decision-Making for Premalignant Pancreatic Cysts." #NYULHSurgery
Tweet media one
0
0
3
@rajarnarayan
Raja Narayan, MD MPH
4 days
@LLUHealth @lovelyday_2010 @AsianAcadSurg @LLUSurgOnc @voguemagazine @RhamiKhorfan @crisa_ilagan_MD @MassGenBrigham @DanaFarber @ZhiVenFongMD @thinzarr @CarlosHFChan Superb performance by @LLUHealth in the #SAAS2025 election ft. @lovelyday_2010 and both incoming + current @LLUSurgOnc fellows, @ReebaSaif (who also won the @AsianAcadSurg Resident/Fellows Development award to attend the @AcademicSurgery Fall Course!) and @crisa_ilagan_MD 👏👏👏
Tweet media one
0
2
7
@shao_connie
Connie Shao | 邵爱华
5 days
Another @AsianAcadSurg meeting, another Associate Member pic! This year featuring @LatinoSurgery - what an amazing group! 🥇
Tweet media one
1
9
35
@rajarnarayan
Raja Narayan, MD MPH
5 days
Timely presentation by @LLUHealth Surgery PGY3 Emily Stevenson and PI @lovelyday_2010 on the disparities in medical-legal access for trauma/EGS patients in the wake of COVID19 @AsianAcadSurg #SAAS2025
Tweet media one
1
2
3
@rajarnarayan
Raja Narayan, MD MPH
5 days
Fantastic talk by @LLUSurgOnc PGY2 Jenny Cevallos on how low-volume sites for performing🤖 distal gastrectomy for gastric 🦀 (<3️⃣cases/y), compared to high-volume sites (>5️⃣), were associated with 🩻❗️bulkier (cN+) disease 🔬❗️more positive margins 📉‼️worse adjusted OS #SAAS2025
Tweet media one
Tweet media two
Tweet media three
Tweet media four
1
3
15
@UnivSurg
Society of University Surgeons (SUS)
1 month
Congrats to @DrPandalai on receiving the 2025 SUS Leadership Agility Program Award!
Tweet media one
3
4
29
@SSATNews
SSAT
2 months
Join the SSAT Resident and Fellows Education Committee on Tuesday, July 15, 2025 for a webinar on Preparing for the ABS General Surgery Boards. This session will cover expert advice to help residents and fellows feel confident for exam day. Register now: https://t.co/56b3U2pnge
Tweet media one
0
4
9
@JSurgRes
Journal of Surgical Research
2 months
For the past 10 years, we have had the great privilege to partner with @AsianAcadSurg. As this terrific organization transitions to @AmJSurgery, we wish them continued growth, success, and impact. Keep up the amazing work, @AsianAcadSurg! It has been an honor working with you.
0
4
16
@Erman_Akkus
Erman Akkus
2 months
🩸Iron Deficiency for the Practicing Oncologist @JCOOP_ASCO ✅A very useful excellent review 👉 https://t.co/Dd6q4oLUmJ @ASCO #cancer #oncology #MedX @OncoAlert @imedverse @isciverse
Tweet media one
Tweet media two
Tweet media three
Tweet media four
3
94
278
@rajarnarayan
Raja Narayan, MD MPH
3 months
Congratulations @ReebaSaif! Looking forward to the amazing things you will do @LLUSurgOnc! 💪
@LLUSurgOnc
Loma Linda University Surgical Oncology
3 months
We are THRILLED to have matched @ReebaSaif as our 2026-2028 @SocSurgOnc fellow! 👩‍🏫 @DowMedical 👩‍⚕️ @UTHealthHouston 👩‍🔬 @theNCI Welcome!
Tweet media one
2
1
17
@AsianAcadSurg
SocAsianAcadSurg
3 months
Join us on June 17th 8pm CST for the next #SAASSips for medical students: How to Excel on Away Rotations Moderated by @gogo_gopss with Drs. Deepa Magge, Jed Calata, @AntiWheatGirl, and @DavidSuMD Register here: https://t.co/hI0WmYQC4k
Tweet media one
0
13
21
@PTarantinoMD
Paolo Tarantino
3 months
Shocking data 🤯 Effect size is huge, way larger than expected Urgent to seek reproduction/validation of the finding in further studies, given the potential implications on clinical practice and clinical trials (across oncology fields)
@StephenVLiu
Stephen V Liu, MD
3 months
This is a major story from #ASCO25. Randomized phase 3 trial of time of day of immunotherapy infusion. Randomized to infusion before or after 3pm. Early infusion far superior: PFS 11.3 vs 5.7 HR 0.42, OS HR 0.45! Impactful, pragmatic, not costly. This should be a bigger story.
Tweet media one
Tweet media two
Tweet media three
Tweet media four
10
42
196
@KrishanJethwa
Krishan Jethwa
3 months
🚨PANOVA-3🚨 Locally advanced PDAC 🔍 Gem + nab-Paclitaxel +/- Tumor Treating Fields (TTF)⚡️ 🔥TTF Demonstrates: ✅⬆️OS ✅⬆️Distant-Met Free Survival ✅⬆️Pain-Free Survival ✅⬆️QoL 🧐A new SoC option for patients with LAPC. While no improvement in local control seem, perhaps
Tweet media one
Tweet media two
Tweet media three
Tweet media four
3
15
28
@KrishanJethwa
Krishan Jethwa
3 months
🚨CASSANDRA🚨 Resectable or BR PDAC 🔍 Neoadjuvant PAXG vs mFOLFIRINOX 🔥PAXG Demonstrates: ✅⬆️EFS ✅⬆️Path response ✅Suggestion of ⬆️OS Has PAXG supplanted FOLFIRINOX as the preferred neoadjuvant systemic tx for localized PDAC?? #ASCO25
Tweet media one
Tweet media two
Tweet media three
Tweet media four
5
21
29
@KrishanJethwa
Krishan Jethwa
3 months
🔥❓Is Pre-op Chemoradiation the new SoC for locally advanced gallbladder cancer❓🔥 🚨POLCA-GB🚨 T3-4 or N+ GB cancer 🔍Gem-Cis +- CRT CRT Demonstrated: ✅⬆️OS, at median and with substantial separation at tail of curve (read: dcurability) ✅⬆️PFS ✅⬆️Objective response ✅No
Tweet media one
Tweet media two
Tweet media three
Tweet media four
4
76
170
@GIMedOnc
Nicholas Hornstein
3 months
#ASCO25 What does >10 MET-hrs/week actually look like and how can we break it down for patients? That was the CHALLENGE trial target —and it delivered a DFS HR of 0.72. But this isn’t just a number. It’s a prescription. 💡 1 MET = resting energy 10 MET-hrs/week = 150–300 min of
@NEJM
NEJM
3 months
Presented at #ASCO25: A 3-year structured exercise program after adjuvant chemotherapy for colon cancer improved disease-free and overall survival, physical functioning, and fitness, as compared with health education alone. Full CHALLENGE phase 3 trial results:
Tweet media one
2
36
79